AKT1 and renal cell carcinoma: Furthermore, hypoxic TAM-derived sEVs-miR-155-5p has been reported to enhance RCC cell proliferation and metastasis through the activation of the HuR-dependent IGF1R/AKT/PI3K pathway, thus promoting RCC progression (Gu et al., 2021).